Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors.

作者: B.D. Hudson , Nicola J. Smith , Graeme Milligan

DOI: 10.1016/B978-0-12-385952-5.00006-3

关键词: GPR120Computational biologyReceptorFatty acidBiologySequence homologySUPERFAMILYBioinformaticsG protein-coupled receptor

摘要: The G protein-coupled receptors (GPCRs) are extremely successful drug targets, with recent estimates suggesting that approximately 30% of all currently available therapeutics act at these receptors. Despite this success, only a small number the over 400 known nonodorant GPCRs targeted, there is still untapped therapeutic potential. However, as most were identified based on their sequence homology to other members superfamily, many remain "orphan" without ligands. Indeed, even once GPCR has been deorphanized, receptor typically poorly characterized in terms its pharmacology and biological functions, presenting unique set experimental challenges order define We discuss some how they have addressed uncover potential five recently deorphanized activated by short- long-chain free fatty acids.

参考文章(188)
Irina G. Tikhonova, Daniel Fourmy, The family of G protein-coupled receptors: an example of membrane proteins. Methods of Molecular Biology. ,vol. 654, pp. 441- 454 ,(2010) , 10.1007/978-1-60761-762-4_23
E. N. Anderson, Hudson et al. Journal of California Anthropology, The. ,vol. 4, ,(1977)
Antonio Nicolucci, Maria Chiara Rossi, Incretin-based therapies: a new potential treatment approach to overcome clinical inertia in type 2 diabetes Acta bio-medica : Atenei Parmensis. ,vol. 79, pp. 184- 191 ,(2008)
Harvey F. Lodish, Molecular Cell Biology ,(1986)
Laura Jenkins, Elisa Alvarez-Curto, Kate Campbell, Sabrina de Munnik, Meritxell Canals, Sabine Schlyer, Graeme Milligan, Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β-arrestin-2 British Journal of Pharmacology. ,vol. 162, pp. 733- 748 ,(2011) , 10.1111/J.1476-5381.2010.01082.X
Miles Congreve, Fiona Marshall, The impact of GPCR structures on pharmacology and structure-based drug design. British Journal of Pharmacology. ,vol. 159, pp. 986- 996 ,(2010) , 10.1111/J.1476-5381.2009.00476.X
David B. Bylund, Myron L. Toews, Radioligand Binding Methods for Membrane Preparations and Intact Cells Methods in Molecular Biology. ,vol. 259, pp. 135- 164 ,(2011) , 10.1007/978-1-61779-126-0_8
Marc Prentki, Christopher J Nolan, Islet β cell failure in type 2 diabetes Journal of Clinical Investigation. ,vol. 116, pp. 1802- 1812 ,(2006) , 10.1172/JCI29103
Kristen L. Pierce, Richard T. Premont, Robert J. Lefkowitz, Seven-transmembrane receptors. Nature Reviews Molecular Cell Biology. ,vol. 3, pp. 639- 650 ,(2002) , 10.1038/NRM908